Dec 22, 2021

Werner Appointed New Senior Director of Clinical Research at Huntsman Cancer Institute

Theresa Werner, MD, has been appointed senior director of clinical research at Huntsman Cancer Institute by Neli Ulrich, PhD, MS, executive director of the Comprehensive Cancer Center. Werner, a physician scientist and associate professor of medicine at the University of Utah.

Dec 21, 2021

Scientists Research New Device to Diagnose Skin Cancer

Detection of skin cancer relies on visual examination, making it hard to reliably determine the skin cancer subtype and its extent of invasion into the skin. Researchers at Huntsman Cancer Institute have developed a potential new device to diagnose skin cancer using an electrical current.

Dec 02, 2021

Scientist in Training Awarded Grant from the Lung Cancer Research Foundation

Aria Vaishnavi, PhD, a postdoctoral fellow at Huntsman Cancer Institute is an awardee of the Lung Cancer Research Foundation 2021 Scientific Grant Program. Vaishnavi will be using this grant to better understand lung cancer caused by inhaled radon gas.

Nov 17, 2021

A Glass-Half-Full Approach to Lung Cancer in the McMahon Lab

Martin McMahon, PhD, and his research group study the genetic mutations that contribute to lung cancer. About 30% of lung cancers can now be treated based on the disease’s specific genetics. McMahon is hopeful that each subset of lung cancer will soon have its own precision treatment.

Oct 13, 2021

Huntsman Cancer Institute Researcher Receives Grant to Study Pediatric Proton Therapy

Huntsman Cancer Institute physician and researcher Matthew Poppe, MD, received a National Cancer Institute grant to study side effects of different types of radiation—proton therapy and traditional radiation therapy—in the treatment of pediatric patients.

Sep 21, 2021

Talks with Docs: Douglas Sborov, Multiple Myeloma Director at HCI

Douglas Sborov, MD, MS, discusses the work being done by the multiple myeloma and clinical trials programs at Huntsman Cancer Institute. He also shares why this work is so meaningful and how a Robin Williams character resonates with him in this latest Talks with Docs.

Jul 28, 2021

Huntsman Cancer Institute Announces Howard Colman, MD, PhD, as Experimental Therapeutics Program Co-Leader

Huntsman Cancer Institute at the University of Utah announced the appointment of Howard Colman, MD, PhD, as the new co-leader of the Experimental Therapeutics Program. Colman is a physician-scientist at HCI, where he holds Jon M. Huntsman Presidential Professorship, and serves as a professor of neurosurgery at the U of U.

May 28, 2021

Six New Cancer Research Fellows Announced by 5 For The Fight

Six new cancer researchers will receive funding through the 5 For The Fight Cancer Research Fellowship, which aims to bring innovative ideas and new ways of thinking to eradicate cancer.

May 21, 2021

Innovative National Clinical Trials in Breast Cancer and Hematologic Cancers Open at Huntsman Cancer Institute

Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG CLL Study S1925, or EVOLVE CLL, an international study evaluating a new approach to chronic lymphocytic leukemia or small lymphocytic lymphoma.

May 10, 2021

Huntsman Cancer Institute Congratulates Faculty on Recent Academic Honors

Huntsman Cancer Institute recognizes new and renewed endowed chairs, along with the distinguished professorship of faculty. Endowed chairs play an important role in creating a partnership between donors and researchers. Distinguished professors are recognized for academic achievements and dedication to teaching.

Apr 01, 2021

Banding Together to Advance Scientific Progress

When cancer researchers from different disciplines work together, they gain new insights into how cancer begins and how it can be treated. HCI is committed to providing an atmosphere where ideas can be created, cultivated, and shared. Here are some examples of how HCI scientists are collaborating to accelerate progress in cancer research.

Mar 29, 2021

Huntsman Cancer Institute Appoints Neeraj Agarwal, MD, as Senior Director of Clinical Research Innovation

Huntsman Cancer Institute announced the appointment of physician-scientist Neeraj Agarwal, MD, as senior director of clinical research innovation. Agarwal will serve on the senior leadership of the Comprehensive Cancer Center at HCI, oversee critical components of HCI’s clinical research infrastructure, and will lead efforts to accelerate the process of bringing new, innovative clinical trial offerings to patients.

Jan 28, 2021

Huntsman Cancer Institute Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

Huntsman Cancer Institute is teaming up with the National Comprehensive Cancer Network®, the American Cancer Society, and other leading organizations across the country to endorse resuming cancer screening and treatment during the ongoing COVID-19 pandemic. The coalition released a letter stating that cancer still poses a major threat to people’s health.

Jan 20, 2021

American Society of Hematology Selects Ami Patel to Receive a 2021 ASH Scholar Award

HCI physician-scientist Ami Patel, MD, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award for her research in leukemia. ASH Scholar Awards are one of ASH’s most prestigious research award programs. They provide financial support to fellows and junior faculty who have dedicated their careers to advancing the field of hematology research as they transition from training programs to careers as independent investigators.

Dec 07, 2020

Huntsman Cancer Institute Treats First Non-Small Cell Lung Cancer Patient on New Phase I Clinical Trial

The first patient in the world to be enrolled on a clinical trial of a new investigational drug, AN0025, was treated at Huntsman Cancer Institute at the University of Utah earlier this year. The drug is being studied for use in patients with non-small cell lung cancer and other solid tumors who have previously been treated with immunotherapy and whose cancers later developed ways to resist immunotherapy.

Dec 03, 2020

Huntsman Cancer Institute Researchers Identify Promising Drug Combination for Melanoma

Researchers at Huntsman Cancer Institute at the University of Utah have identified a potential drug combination to treat uveal melanoma, a type of eye cancer. Lead author Amanda Truong, trainee in the McMahon Lab at HCI, explains uveal melanoma patients frequently have changes in genes called GNAQ and GNA11, which are key targets for these drugs. This study was published in the journal Clinical Cancer Research.

Nov 27, 2020

Fighting Melanoma and Other Cancers Using Immunotherapy

For Siwen Hu-Lieskovan, MD, PhD, it was the promise of immunotherapy—that is, harnessing the body’s own immune system to fight cancer—that inspired her to get into cancer research. Training under one of the pioneers of immunotherapy, she witnessed amazing survival stories of patients. The project Hu-Lieskovan proposed for the 5 For The Fight grant is to tackle the immune-related adverse events when adding different immunotherapies.

Nov 12, 2020

Huntsman Cancer Institute Researcher Receives National Cancer Clinical Investigator Team Leadership Award

Siwen Hu-Lieskovan, PhD, MD, physician scientist at Huntsman Cancer Institute and assistant professor of medicine at the University of Utah, has received the National Cancer Institute 2020 Cancer Clinical Investigator Team Leadership Award. The award recognizes outstanding clinical investigators at NCI-designated Cancer Centers who participate extensively in NCI-funded clinical trials, and whose leadership and activities promote a successful culture of collaborative clinical research.

Nov 10, 2020

HCI Researcher Receives Two Awards for Community Contributions and Neuroendocrine Tumor Research

Heloisa Soares, MD, PhD, a gastrointestinal and neuroendocrine tumor medical oncologist and researcher at Huntsman Cancer Institute and assistant professor of internal medicine at the University of Utah, received two awards from external organizations honoring her contributions to the field of cancer. Soares was named an Advocacy Champion by the American Society of Clinical Oncology. Soares also received the 2020 North American Neuroendocrine Tumor Society Theranostics Investigator Grant.

Oct 22, 2020

Letter of Hope: Breast Cancer Research in the Welm Labs

Dear patients, please know this as you go through your breast cancer treatment journey. The dedicated technical staff, PhD students, and postdoctoral fellows in the Welm Labs continue to work hard every day (and night!) to bring new hope to people with metastatic breast cancer through innovative research, always with patients in mind.

Oct 20, 2020

Talks with Docs: Samuel Cheshier, Pediatric Neurosurgeon

“I just love taking care of them, helping make them better,” says pediatric neurosurgeon Samuel Cheshier about the children he treats at Huntsman Cancer Institute and Primary Children’s Hospital. He talks about what he has learned from these kids and their parents, what patients should know about Huntsman Cancer Institute, and what he reads about in his spare time.

Oct 16, 2020

Fighting Brain Tumors in Kids

When Samuel Cheshier was 13 years old, his favorite cousin died of colon cancer. “I always think of him when I do cancer research,” Cheshier says. As a pediatric neurosurgeon, he witnesses firsthand the devastation that malignant brain tumors cause patients and their families. The desire to help them motivates his basic science research, with the goal of translating experiments into therapies. The 5 for the Fight Fellowship will help speed up the pace of his research, allowing him to start a new project.

Sep 29, 2020

5 For The Fight Announces Inaugural Class of Cancer Research Fellows at Huntsman Cancer Institute

5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, today announced the inaugural recipients of the 5 For The Fight Cancer Research Fellowship in partnership with Huntsman Cancer Institute at the University of Utah.

Sep 18, 2020

Committed to a Positive and Lasting Impact: The Engelstad Foundation

Samuel Cheshier, MD, PhD, and the Neurologic Cancers Center team at Huntsman Cancer Institute are working to find better treatments for brain cancer, particularly pediatric brain cancer. Many primary brain tumors are incurable from the start, and currently, none are curable once they recur. The need for novel, effective therapies is critical. In 2020, the Engelstad Foundation funded a $100,000 grant at HCI to study a potential immunotherapy treatment for pediatric brain tumors.

Sep 10, 2020

Novel Discovery Challenges a Current Kidney Cancer Paradigm

Newly published research has reversed our understanding of an aspect of kidney tumor growth. Researchers at Huntsman Cancer Institute at the University of Utah discovered that two key proteins have opposite roles than what was previously believed.

Aug 04, 2020

Scientists Develop New Models to Accelerate Progress in Preventing Drug Resistance in Lung and Pancreas Cancers

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports.

Jul 31, 2020

Huntsman Cancer Institute Research Illuminates Potential New Treatment Approach in Acute Myeloid Leukemia

In a study published in the journal Leukemia, lead author Ami Patel, MD, showed that factors produced by bone marrow support cells allowed leukemia cells to survive treatment with quizartinib, a type of TKI.

Jul 21, 2020

Huntsman Cancer Institute Receives Renewal of Prestigious Designation from the National Cancer Institute

The National Cancer Institute has renewed the designation of Huntsman Cancer Institute (HCI) at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization. This grant awards HCI more than $29 million over seven years, an increase of 84% in annual funding from the previous award cycle.

Jul 17, 2020

Talks with Docs: Heloisa Soares, GI Oncologist

Heloisa Soares, MD, PhD, is not simply a GI oncologist or neuroendocrine tumor expert. She is also a passionate patient advocate and had the opportunity to meet members of Congress about improved patient care. Learn about her advocacy work, Brazilian upbringing, and more.

May 27, 2020

Utah Researcher Awarded Prestigious Grant to Study New Ways to Detect Brain Tumors

Hunter Underhill, MD, PhD, a Huntsman Cancer Institute brain cancer researcher and assistant professor of pediatrics at the University of Utah, was awarded a special National Cancer Institute grant to advance his research in brain tumor detection. Underhill will pursue new ways to detect glioblastoma, a type of aggressive and deadly brain tumor.

May 26, 2020

Melanoma Research Innovations

At Huntsman Cancer Institute, we're committed to delivering a cancer-free frontier. Our cancer researchers are on the cutting-edge of discovery and innovation, and we're excited by what these advancements mean for melanoma prevention and treatment. Together, we're building the future we want.

Apr 24, 2020

Research Advancing Individualized Treatment for Metastatic Prostate Cancers

Prostate cancer is the second most common cancer for men in the United States. About one man in nine will be diagnosed with the disease at some point in his life. A study recently published in The Lancet’s EBioMedicine Journal describes new insights into how unique genetic traits of metastatic prostate tumors that are shed into the blood of cancer patients can be used for applying to the care of and potential molecularly targeted treatments in individual patients.

Mar 09, 2020

HCI Post-Doctoral Fellow Receives Award from the National Cancer Institute

Aria Vaishnavi, PhD, a post-doctoral fellow at Huntsman Cancer Institute at the University of Utah has received the first annual National Cancer Institute Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers. The “Early K99” grant supports researchers who need only a short period of training and mentorship after their doctoral degrees and before they’re hired into a faculty position.

Mar 04, 2020

Talks with Docs: John Ward, Breast Oncologist and Hematologist

John Ward, MD, has been a part of Huntsman Cancer Institute since its doors first opened. He now serves as Interim Senior Director of Clinical Affairs and the Interim Physician in Chief. Dr. Ward is honored to be associated with people who face cancer in their lives and tells us what he's learned from his patients after his 25 years at Huntsman Cancer Institute.

Mar 01, 2020

Ahorrando mucho más que el tiempo: la radioterapia acortada

Traditionally, breast cancer patients who receive radiation get small doses almost daily over a six- to seven-week period. Radiation oncologists are now seeking to shorten that time through clinical trials.

Mar 01, 2020

Mensaje de John Ward

Hace más de dos décadas, tuve el privilegio de ser miembro del equipo al que se le dio una oportunidad extraordinaria: trabajar junto a Jon M. y Karen Huntsman y nuestros colegas de la Universidad de Utah para transformar la forma en que brindamos atención del cáncer en Utah. Nos propusimos hacer algo que una vez se creyó imposible. Nos propusimos desarrollar un hospital de cáncer de clase mundial y un centro de investigación, Huntsman Cancer Institute (HCI por sus siglas en inglés).

Mar 01, 2020

De la noción al conocimiento: la investigación oncológica salva vidas

Las pruebas clínicas en Huntsman Cancer Institute (HCI por sus siglas en inglés) ayudan a encontrar mejores formas de prevenir, diagnosticar y tratar el cáncer, al poner a prueba la seguridad y efectividad de nuevos fármacos y tratamientos. En promedio, existen 150-200 ensayos clínicos abiertos a pacientes de HCI en cualquier momento dado.

Mar 01, 2020

Saving More Than Time: Shortened Radiation Therapy

Traditionally, breast cancer patients who receive radiation get small doses almost daily over a six- to seven-week period. Radiation oncologists are now seeking to shorten that time through clinical trials.

Mar 01, 2020

Message from John Ward

More than two decades ago, I had the privilege of being a member of the team given an extraordinary opportunity: to work alongside Jon M. and Karen Huntsman and our colleagues at the University of Utah to transform the way we deliver cancer care in Utah. We set out to do something once thought impossible. We set out to develop a world-class cancer hospital and research center—Huntsman Cancer Institute (HCI).

Mar 01, 2020

From Notion to Knowledge: Cancer Research Saves Lives

Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average, there are between 150–200 clinical trials open to HCI patients at any given time.

Feb 25, 2020

Huntsman Cancer Institute Translational Scholars: Courtney Scaife, MD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Courtney Scaife, MD, was recently honored with a Huntsman Translational Scholar award.

Feb 07, 2020

New CAR-T Target Yields Promising Results for Multiple Myeloma

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism. In research published in the journal Nature Communications, HCI scientists describe a novel way to treat cancers using chimeric antigen receptor (CAR) T cell therapy.

Jan 13, 2020

Huntsman Cancer Institute Translational Scholars: Randy Jensen, MD, PhD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Randy Jensen, MD, PhD, was recently honored with a Huntsman Translational Scholar award.

Sep 30, 2019

International Lifetime Achievement Award in Leukemia Research Awarded to Michael Deininger, MD, PhD

The International Chronic Myeloid Leukemia Foundation (iCMLf) has awarded the prestigious Rowley Prize to Michael Deininger, MD, PhD. Deininger’s selection as the 2019 awardee was announced in February. Formal presentation of the prize occurred at an international scientific conference in Bordeaux, France, earlier this month.

Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 06, 2019

Caring for Patients with a Family History of Pancreatic Cancer

Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas cancer screening strategies for certain patients with a family history of the disease.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.

May 13, 2019

New Insights into Treatment Targets for Men with Advanced Prostate Cancers

In the largest study of its kind, more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies

Apr 08, 2019

Huntsman Cancer Institute Announces Interim Clinical Leaders

Two physicians at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) are stepping into interim clinical leadership roles.

Mar 12, 2019

Huntsman Translational Scholars: Matthew Poppe, MD

Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve clinical problems and benefit patients through new diagnostic and therapeutic approaches.

Mar 04, 2019

Promising New Pancreatic Cancer Treatment Moves Forward

A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) describes a new therapeutic approach with potential for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. HCI researchers first observed anti-cancer impacts in a laboratory setting and, subsequently, in its first use in a human patient.

Mar 01, 2019

Exercise for Improved Outcomes

The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can improve long-term outcomes after lung cancer surgery.

Mar 01, 2019

Together We Care Compassionately

Approximately 500 patients visit the outpatient clinics and infusion center at Huntsman Cancer Institute each day. Our patients rely on our clinical teams and staff to provide safe, efficient, and high quality care during each clinic visit. In this letter from Don Milligan, director of outpatient services, highlights recent efforts to provide the best care possible.

Mar 01, 2019

Clinical Trials: A Look at Recent Progress

Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ways to prevent, diagnose, or treat cancer. At any given time, Huntsman Cancer Institute has an average of 200 clinical trials open to cancer patients.

Mar 01, 2019

Pancreas Discovery Moves from Lab to Clinic

In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.

Mar 01, 2019

Breaking Ground for Proton Therapy

When construction is complete in 2021, Huntsman Cancer Institute will implement the latest advance in proton therapy, called intensity-modulated proton therapy. Proton therapy is the favored approach for many tumors in and around vital structures such as the spinal cord and brain stem. It is also the preferred treatment for certain childhood cancers. We are committed to bringing cutting-edge care to our patients, and proton therapy will be the next step in that promise.

Mar 01, 2019

A Passion for Advancing Research and Improving Patient Care

HCI patient Clark Stringham felt like he was running out of time with his diagnosis of advanced prostate cancer. He credits a clinical trial and his oncologist, Neeraj Agarwal, MD, with saving his life.

Feb 11, 2019

Talks with Docs: Ignacio Garrido-Laguna, GI Oncologist

Ignacio Garrido-Laguna, MD, PhD, is a gastrointestinal oncologist with a special interest in pancreas cancer. In this interview, he tells us about his home and his medical training in Spain, including how it is similar to Utah, as well as his vision for the future of pancreas cancer.

Feb 08, 2019

Last Year’s Biggest Advances in Cancer Research

The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past year and looks ahead to future research priorities. Two physician-scientists from Huntsman Cancer Institute contributed to the report.

Jan 07, 2019

Huntsman Translational Scholars: Thomas Varghese Jr., MD, MS

HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Thomas Varghese Jr, MD, MS, was recently honored with a Huntsman Translational Scholar award.

Nov 20, 2018

The Pancreatic Cancer Collective awards $7 million in first-round “New Therapies Challenge” Grants

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today. Each team will receive up to $1 million in initial funding, with $4 million per team for clinical studies awaiting the most successful projects in the second round.

Nov 20, 2018

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center

Officials at Huntsman Cancer Institute at the University of Utah began construction on a project that will house the region’s first proton therapy center and announced the new center will be named in honor of United States Senator Orrin G. Hatch. Cancer patients and loved ones joined leaders from HCI, Huntsman Cancer Foundation, and the university to mark the occasion.

Nov 15, 2018

Huntsman Cancer Institute Announces New Phase I Clinical Trial Director

Huntsman Cancer Institute at the University of Utah has appointed Ignacio Garrido-Laguna, MD, PhD, as director of its Phase I Clinical Trials unit. In this position, Garrido-Laguna will oversee all aspects of HCI’s Phase I clinical trials.

Oct 18, 2018

Shedding Light on the Complex World of Prostate Cancer Treatment at the 2018 Cancer Summit

Many men feel overwhelmed by options when deciding how to treat their prostate cancer. To educate community members on this complex topic, Huntsman Cancer Institute joined our affiliate hospital St. John's Medical Center at the 2018 Cancer Summit to discuss advances in prostate cancer diagnosis and care.

Oct 11, 2018

Study Holds Promise for New Pediatric Brain Tumor Treatment

New research published in Nature Communications from scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer.

Oct 02, 2018

Huntsman Cancer Institute and Grand Valley Oncology Begin Telemedicine Clinic for Blood and Bone Marrow Transplant Patients

Huntsman Cancer Institute at the University of Utah, in partnership with Grand Valley Oncology, recently opened a telemedicine clinic to serve blood and marrow transplant patients in Mesa County, Colorado and the surrounding areas. This service will bring cutting-edge care to remote communities without requiring the patient to travel long distances to Salt Lake City for follow-up appointments.

Sep 19, 2018

Huntsman Translational Scholars: Ignacio Garrido-Laguna, MD, PhD

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist who treats patients with pancreatic cancer.

Sep 18, 2018

Talks with Docs: Deborah Stephens, DO

Dr. Deborah Stephens cares for patients with lymphoma and chronic lymphocytic leukemia and researches these diseases. In this episode of Talks with Docs, she shares the importance of caring for the whole patient and how becoming a parent has changed her.

Sep 11, 2018

Talks with Docs: Thomas Varghese, MD

Tom Varghese, MD, is a thoracic surgeon who treats patients with lung cancer at Huntsman Cancer Institute. But did you know he's also an amateur cartoonist who's passionate about gender equity in the medical field?

Aug 01, 2018

Study of Utah Lung Cancer Patients Finds Those Who Never Smoked May Have Genetic Predisposition for Cancer

Despite Utah's low smoking rate, lung cancer remains the leading cause of cancer death in Utah. In addition, lung cancer in people who have used tobacco and people who have never smoked behaves differently. Researchers at Huntsman Cancer Institute wanted to know why.

Jul 31, 2018

Huntsman Translational Scholars: Howard Colman, MD, PhD

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Howard Colman, MD, PhD is a physician-scientist specializing in the treatment of brain tumors and the diagnosis and management of neurologic complications of cancer.

Jul 13, 2018

Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center

Huntsman Cancer Institute at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment.

Jul 11, 2018

Huntsman Cancer Institute Researcher Receives Leadership Award from the National Cancer Institute

Huntsman Cancer Institute physician-scientist Ahmad Halwani, MD, has been selected by the National Cancer Institute to receive a Cancer Clinical Investigator Team Leadership Award. This award recognizes physician-scientists for their contributions to clinical cancer research. It also provides financial support for ongoing research and leadership development to enable recipients to further advance their clinical research careers.

Jul 09, 2018

Huntsman Translational Scholars: Adam Cohen, MD, MS

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.

Jun 14, 2018

Huntsman Cancer Institute Physicians Attend and Share Expertise at National Cancer Meeting

“Delivering Discoveries: Expanding the Reach of Precision Medicine,” was the theme of the American Society of Clinical Oncology (ASCO) 2018 annual meeting held June 1-5, 2018 in Chicago. One of the largest scientific conferences in the world, the meeting brings together nearly 40,000 attendees and features thousands of studies about new ways to prevent, detect, and treat cancer.

May 23, 2018

Huntsman Translational Scholars: Deborah Stephens, DO

HCI established the Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of Hematology Clinical Trials at Huntsman Cancer Institute and is also an assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.

May 18, 2018

Space Could Be the New Frontier for Cancer Research

On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.

May 10, 2018

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

May 09, 2018

Huntsman Translational Scholars: Theresa Werner, MD

HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.

Mar 15, 2018

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

Huntsman Cancer Institute at the University of Utah has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society. The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Mar 08, 2018

Talks with Docs: Theresa Werner, MD

Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.

Feb 15, 2018

Message from HCI's CEO

The West is known for its "can-do" spirit, for the willingness of people to work together. At Huntsman Cancer Institute, we strive to push the boundaries of cancer research and care and attain results beyond what we thought was possible. We've made a commitment to advance cutting-edge cancer research and care in the Mountain West region.

Feb 15, 2018

Bench to Bedside

Advancing discoveries made in the lab to medical treatments that can be used in patient care is complex and time-consuming. Commonly called clinical translation, this process can be thought of much like translating something from one language to another.

Feb 15, 2018

Total Cancer Care: Coming Together to Find Cures

Christina Ratcliff enrolled in HCI's Total Cancer Care study, a partnership among patients, health care providers, and researchers to help accelerate cancer research and improve patient care.

Feb 15, 2018

Training the Next Generation of Cancer Researchers

Over the years, there have been many landmark discoveries in the effort to eradicate cancer. Progress can only continue with well-trained and passionate researchers and physicians. Huntsman Cancer Institute faculty work with students of all ages to cultivate the next generation of scientists who will carry on this life-saving work.

Dec 22, 2017

New Endowed Chair Holders at HCI

Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.

Nov 27, 2017

Huntsman Cancer Institute Researchers Trace Timeline of Tumor Evolution in Metastatic Breast Cancer Patients

A new study by researchers at Huntsman Cancer Institute (HCI) at the University of Utah observed how breast cancer tumors evolve over time and demonstrated how changes within tumors may contribute to the process by which cancers no longer respond to treatment. Further, the research identifies that some of these changes may be shared across certain treatment-resistant breast cancers. The study was published this month in Nature Communications.

Nov 27, 2017

Talks with Docs: Randy Jensen, MD, PhD

Dr. Randy Jensen—auto racer, canyoneer, triathlete, and neurosurgeon—chats with us about his many life adventures.

Nov 15, 2017

HCI Trainee Receives NCI Graduate Diversity Supplement

Kali Dale, a graduate research assistant at HCI, was selected to receive the National Cancer Institute Graduate Diversity Supplement.

Nov 14, 2017

Huntsman Cancer Institute Expanding Access to Clinical Trials

All cancer treatments and medications that are used today, at one point, were clinical trials. Clinical trials can offer hope, particularly in a complex disease like cancer. But getting access to clinical trials can be difficult, especially if patients have to travel a long distance to a hospital that offers trials.

Oct 07, 2017

Talks with Docs: Jonathan Tward, MD, PhD

Jonathan Tward, MD, PhD, explains how he began his career as a radiation oncologist, what he's learned from his patients, and why he loves an unusual sport.

Sep 22, 2017

Huntsman Cancer Institute Announces New Clinical Research Director

Huntsman Cancer Institute (HCI) at the University of Utah has announced David Gaffney, MD, PhD, as Senior Director for Clinical Research. In this position, Gaffney oversees HCI’s clinical research efforts which include more than 200 active clinical cancer trials at any given time.

Jul 18, 2017

Study Shows Shorter Course of Radiation May Be a Safe and Convenient Option for Breast Cancer Patients after Mastectomy

Research published in the Journal of Clinical Oncology demonstrates that a shorter course of radiation may be a good option for breast cancer patients who need radiation following mastectomy. The Phase II clinical trial examined the safety of treating women with a three-week course of radiation instead of the traditional six weeks.

Jul 11, 2017

Cancer Researchers in Training: Studying What Makes Each Cell Unique

RNA modification is an area of cell biology few people have studied, and the idea of exploring the boundaries of the known world is what first attracted graduate student Archana Yerra to a career in science.

Jun 20, 2017

Grand Valley Oncology Announces Clinical Trials Open to Patients

Mesa County, Colo.--- Grand Valley Oncology with the support of Huntsman Cancer Institute (HCI) at the University of Utah will offer a range of clinical trials for their patients. Physicians at Grand Junction Oncology will work closely with their counterparts at HCI to identify opportunities for patients in western Colorado to participate in clinical trials.

May 30, 2017

Huntsman Cancer Institute at the University of Utah Selected to Join National Cancer Institute’s Systems Biology Consortium

SALT LAKE CITY – Huntsman Cancer Institute (HCI) and the College of Pharmacy at the University of Utah (U of U) have been awarded a $9.1 million, five-year grant from the National Cancer Institute (NCI) to serve as a Research Center in NCI’s Cancer Systems Biology Consortium (CSBC). HCI is one of nine research institutions nationwide to be selected as a Research Center in the CSBC.

Apr 12, 2017

Huntsman Cancer Institute Investigators Elected to American Academy of Arts and Sciences

University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.

Feb 24, 2017

HCI Researcher Receives Merit Award for Prostate Cancer Research

Huntsman Cancer Institute researcher Andrew Hahn, MD, received the Conquer Cancer Foundation of ASCO Merit Award. The award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.

Jan 01, 2017

HCI CEO and Director Serves as Panelist at White House Event

Mary Beckerle, PhD, CEO of Huntsman Cancer Institute, served as a panelist at an event organized by the White House Cancer Moonshot Task Force. Beckerle participated in a discussion on addressing disparities in access to cancer prevention, diagnosis, and treatment.

Sep 29, 2016

Huntsman Cancer Institute at the University of Utah Announces New Leadership

SALT LAKE CITY—Officials at University of Utah Health Care (UUHC) today announced that Ben Tanner, Huntsman Cancer Institute’s (HCI) current director of clinical operations and chief operating officer (COO) has been named the cancer hospital’s executive director, replacing Ray Lynch, who is retiring after 13 years of service. Tanner will assume his duties immediately.